TY  - GEN
AU  - Bajetta,E
AU  - Celio,L
AU  - Ferrario,E
AU  - Di Bartolomeo,M
AU  - Denaro,A
AU  - Dotti,K
AU  - Mancin,M
AU  - Bajetta,R
AU  - Colombo,A
AU  - Pusceddu,S
TI  - Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer
SN  - 1569-8041
PY  - 2008///0116
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biopsy, Needle
KW  - Camptothecin
KW  - administration & dosage
KW  - Capecitabine
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Confidence Intervals
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunohistochemistry
KW  - Irinotecan
KW  - Liver Neoplasms
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Staging
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1093/annonc/mdm347
ER  -